Table 2: Mean Value of Original scores of IgG, kappa and lambda, and Current Reading of 3 markers over Time in group A (FSGS) and group B cases (immune complex mediated glomerulopathy [ICMG])

Control A ICMGN, B1 ICMGN, B2 ICMGN, B3
n 21 12 10 13
Original Staining IgG 0.05 ± 0.05 2.83 ± 0.12 3.00 ± 0.00 2.77 ± 0.12
Original Staining kappa 0 ± 0 2.16 ± 0.21 2.50 ± 0.22 2.39 ± 0.18
Original Staining lambda 0 ± 0 1.91 ± 0.23 2.10 ± 0.23 2.54 ± 0.14
1st F-U months 12-18 12 -18 6-11 1-5
1st F-U IgG 0.03 ± 0.03 2.50 ± 0.20 2.20 ± 0.15 2.69 ± 0.13
1st F-U Kappa 0 ± 0 2.08 ± 0.19 2.00 ± 0.21 2.46 ± 0.18
1st F-U Lambda 0 ± 0 1.67 ± 0.14 2.00 ± 0.21 2.46 ± 0.14
2nd F-U months 53-58 53-58 46-52 40-45
2nd F-U IgG 0 ± 0 1.09 ± 0.09*# 1.09 ± 0.09*# 1.50 ± 0.23*#
2nd F-U Kappa 0 ± 0 0.64 ± 0.15*# 0.67 ± 0.14*# 1.09 ± 0.23*#
2nd F-U lambda 0 ± 0 0.64 ± 0.15*# 0.50 ± 0.15*# 1.33 ± 0.19*#


* vs Original and # vs 1st follow-up (F-U),P value<0.05=significance. B1 - Subgroup of B with the first follow-up at 12 - 18 months and the second follow-up at 53 - 58 months, B2 with the first follow-up at 6 - 11 months and the second follow-up at 53 - 58 months, and B3 with the first follow-up at 1 - 5 months and the second follow-up at 40 - 45 months.